Investigational Site Number :1910002

Zagreb 10000

4 studies enrolling now · 7 studies all time

What they study most

Cerebroside Lipidosis Syndrome, Fabry Disease, Gaucher Disease, Glucocerebrosidase Deficiency Disease, Glucosylceramide Beta-Glucosidase Deficiency Disease, Glycogen Storage Disease Type II, Glycogen Storage Disease Type II (GSD-II), Glycogenesis 2 Acid Maltase Deficiency, Pompe Disease, Pompe Disease (Late-onset), Primary Progressive Multiple Sclerosis, Progressive Relapsing Multiple Sclerosis

Studies at this site

• Fabry Disease Registry & Pregnancy Sub-registry — Recruiting now
• Pompe Disease Registry Protocol — Recruiting now
• Pompe Pregnancy Sub-Registry — Recruiting now
• International Collaborative Gaucher Group (ICGG) Gaucher Disease Registry & Pregnancy Sub-registry — Recruiting now
• A Study to Investigate Long-term Safety and Tolerability of Tolebrutinib in Participants With Multiple Sclerosis. — Running, not enrolling
• Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (PERSEUS) — Completed
• Relapsing Forms of Multiple Sclerosis (RMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (GEMINI 2) — Completed